News Daily News The Case for Collateralization: CABG’s Mechanism for Survival in Stable CAD Underappreciated by Patients L.A. McKeown February 26, 2019
News Daily News New Equations Help ID Patients at Low Risk for Bleeding With Aspirin Michael O'Riordan February 26, 2019
News Daily News DOACs Maintain Advantage Over Warfarin in A-fib Patients With Low Body Weight Todd Neale February 25, 2019
News Daily News FDA Adds Boxed Warning About CV Risks to Gout Drug Febuxostat Shelley Wood February 22, 2019
News Daily News Long Bouts of Sedentary Time Linked to CVD Risk in Women Michael O'Riordan February 20, 2019
News Daily News Hormone Therapy Ups CV Risk in Transgender Individuals Caitlin E. Cox February 18, 2019
News Daily News Lower Statin Adherence Linked to Higher Mortality Risk, Even Among Patients With Established ASCVD Lucy Hicks February 15, 2019
News Conference News ISC 2019 Should Pioglitazone Be Used More for Secondary Stroke Prevention in Prediabetes? Todd Neale February 14, 2019
News Conference News ISC 2019 Final ANNEXA-4 Results Published, Confirm Rapid Andexanet Alfa Effects Todd Neale February 13, 2019
News Conference News ISC 2019 Cilostazol-Based DAPT Safe, Effective in Patients at High Risk for Recurrent Stroke Todd Neale February 12, 2019
News Conference News ISC 2019 Getting Women More Involved at the International Stroke Conference: Theories, Data, and Solutions Todd Neale February 12, 2019
News Daily News Human Papilloma Virus May Contribute to CVD Risk in Women, Korean Study Finds L.A. McKeown February 08, 2019
News Daily News Age Shouldn’t Be a Barrier to Statin Therapy, Meta-analysis Suggests Michael O'Riordan February 08, 2019
News Conference News ISC 2019 Off-Label Underdosing of DOACs Tied to Worse Outcomes in A-fib Patients Todd Neale February 07, 2019
News Conference News ISC 2019 Opioid Epidemic Brings Higher Rates of Endocarditis, Stroke Todd Neale February 06, 2019
News Daily News One in Two Americans Have Cardiovascular Disease: AHA Stats Michael O'Riordan February 04, 2019
News Features Hopes Fade for a CV Indication for Canakinumab: What’s Next for the Inflammatory Hypothesis? Michael O'Riordan February 01, 2019
News Daily News Go With NOACs Over Warfarin in Most Cases: Updated A-fib Guidelines Todd Neale January 29, 2019
News Daily News Aspirin as Primary Prevention Curbs CV Events but Ups Major Bleeding, Too: Meta-analysis Caitlin E. Cox January 24, 2019
News Daily News Dose-Response Benefits for Fiber Intake Seen Across Wide Swath of Acquired Diseases Shelley Wood January 15, 2019